Blood Glucose Meters - Medical Devices Pipeline Assessment, 2019

GlobalData's Medical Devices sector report, "Blood Glucose Meters - Medical Devices Pipeline Assessment, 2019", provides an overview of Blood Glucose Meters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Blood Glucose Meters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Blood Glucose Meters under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Blood Glucose Meters and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Blood Glucose Meters under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Blood Glucose Meters Overview

3 Products under Development

• 3.1 Blood Glucose Meters - Pipeline Products by Stage of Development
• 3.2 Blood Glucose Meters - Pipeline Products by Segment
• 3.3 Blood Glucose Meters - Pipeline Products by Territory
• 3.4 Blood Glucose Meters - Pipeline Products by Regulatory Path
• 3.5 Blood Glucose Meters - Pipeline Products by Estimated Approval Date
• 3.6 Blood Glucose Meters - Ongoing Clinical Trials

4 Blood Glucose Meters - Pipeline Products under Development by Companies

• 4.1 Blood Glucose Meters Companies - Pipeline Products by Stage of Development
• 4.2 Blood Glucose Meters - Pipeline Products by Stage of Development

5 Blood Glucose Meters Companies and Product Overview

• 5.1 4a Medicom GmbH Company Overview
• 5.2 A. Menarini Diagnostics Srl Company Overview
• 5.3 Abbott Diabetes Care Inc Company Overview
• 5.4 Advanced Biosensors-Ohio LLC (Inactive) Company Overview
• 5.5 Advanced Medical Electronics Corp Company Overview
• 5.6 Alertgy Inc Company Overview
• 5.7 Arkal Medical, Inc. (Inactive) Company Overview
• 5.8 Arkray Inc Company Overview
• 5.9 Ascensia Diabetes Care Holdings AG Company Overview
• 5.10 Azurite Technologies, Inc. (Inactive) Company Overview
• 5.11 Bar-Ilan University Company Overview
• 5.12 Baylor University Company Overview
• 5.13 Biopeak Corp Company Overview
• 5.14 Biorasis Inc Company Overview
• 5.15 BioTex Inc Company Overview
• 5.16 Biovotion AG Company Overview
• 5.17 Brain Beat Ltd Company Overview
• 5.18 Brigham and Women's Hospital Company Overview
• 5.19 Cactus Semiconductor Inc Company Overview
• 5.20 CALISTO MEDICAL, INC. (Inactive) Company Overview
• 5.21 Callitas Therapeutics Inc Company Overview
• 5.22 Cardiff University Company Overview
• 5.23 CGM3 Ltd Company Overview
• 5.24 City, University of London Company Overview
• 5.25 Columbia University Company Overview
• 5.26 ConvaTec Group Plc Company Overview
• 5.27 Co-Optical Inc Company Overview
• 5.28 Cyber Medical Ltd Company Overview
• 5.29 Debiotech SA Company Overview
• 5.30 DexCom Inc Company Overview
• 5.31 DiaMonTech GmbH Company Overview
• 5.32 DirectSens GmbH Company Overview
• 5.33 Echo Therapeutics Inc Company Overview
• 5.34 Ecole Polytechnique Federale de Lausanne Company Overview
• 5.35 eLutions Integrated Systems, Inc. Company Overview
• 5.36 Emperra GmbH E-Health Technologies Company Overview
• 5.37 EyeSense GmbH Company Overview
• 5.38 Firefly Health Pty Ltd Company Overview
• 5.39 Flowsion A/S Company Overview
• 5.40 Gili Medical Ltd Company Overview
• 5.41 Globe Medical Tech Inc (Inactive) Company Overview
• 5.42 GlucoLight Corporation (Inactive) Company Overview
• 5.43 GlucoMe Ltd Company Overview
• 5.44 Glucometrix AG Company Overview
• 5.45 Glucosat Company Overview
• 5.46 Glucosense Diagnostics Ltd (Inactive) Company Overview
• 5.47 GlucoSet AS Company Overview
• 5.48 GlucoStats System Pte Ltd. Company Overview
• 5.49 Glucovation Inc Company Overview
• 5.50 GluMetrics Inc Company Overview
• 5.51 Glusense Ltd Company Overview
• 5.52 GlySens Inc Company Overview
• 5.53 G-Sense Ltd. Company Overview
• 5.54 iGlyko, Inc. (Inactive) Company Overview
• 5.55 Indigo Diabetes NV Company Overview
• 5.56 InLight Solutions Inc. Company Overview
• 5.57 Innopharmax Inc Company Overview
• 5.58 Innovosens AB Company Overview
• 5.59 Insulet Corp Company Overview
• 5.60 Integrated Medical Sensors Company Overview
• 5.61 Integrity Applications Ltd Company Overview
• 5.62 IntelliDx Inc (Inactive) Company Overview
• 5.63 Invivomon Inc (Inactive) Company Overview
• 5.64 Invivosense ASA (Inactive) Company Overview
• 5.65 I-Sens Inc Company Overview
• 5.66 iSense Corporation (Inactive) Company Overview
• 5.67 KeenCAT Technologies Company Overview
• 5.68 Keratin Biosciences Inc Company Overview
• 5.69 Know Labs Inc Company Overview
• 5.70 KTH Royal Institute of Technology Company Overview
• 5.71 Lein Applied Diagnostics Limited Company Overview
• 5.72 LEMM Technologies, LLC Company Overview
• 5.73 LifeScan Inc Company Overview
• 5.74 LighTouch Medical, Inc. Company Overview
• 5.75 Luminous Medical Inc (Inactive) Company Overview
• 5.76 Lyte Labs Company Overview
• 5.77 Massachusetts Institute of Technology Company Overview
• 5.78 Medical Wireless Sensing Ltd Company Overview
• 5.79 Medtronic Diabetes Company Overview
• 5.80 Medtronic plc Company Overview
• 5.81 Mellitor Ltd Company Overview
• 5.82 Metronom Health Inc Company Overview
• 5.83 MIMOS Berhad Company Overview
• 5.84 mobiLIFE Company Overview
• 5.85 Mologic Ltd Company Overview
• 5.86 Nagasaki University Company Overview
• 5.87 Nemaura Medical Inc Company Overview
• 5.88 Newton Photonics Inc Company Overview
• 5.89 NIR Diagnostics Inc. (Inactive) Company Overview
• 5.90 Northwestern University Company Overview
• 5.91 Orsus Medical Ltd Company Overview
• 5.92 Pelikan Technologies, Inc. (Inactive) Company Overview
• 5.93 Pepex Biomedical, Inc. Company Overview
• 5.94 PharmaTech Solutions Inc Company Overview
• 5.95 Pignolo SpA Company Overview
• 5.96 Pkvitality Company Overview
• 5.97 POPS! Diabetes Care Inc Company Overview
• 5.98 PositiveID Corp Company Overview
• 5.99 Prediktor Medical AS Company Overview
• 5.100 Profusa Inc Company Overview
• 5.101 Purdue University Company Overview
• 5.102 Q Step Technologies, Inc. Company Overview
• 5.103 Roche Diabetes Care Inc Company Overview
• 5.104 San Meditech (Huzhou) Co., Ltd. Company Overview
• 5.105 Senseonics Holdings Inc Company Overview
• 5.106 SensiVida Medical Technologies, Inc. (Inactive) Company Overview
• 5.107 Sensyne Health Plc Company Overview
• 5.108 Sensys Medical, Inc. Company Overview
• 5.109 Sentec Pte Ltd Company Overview
• 5.110 Senzime AB Company Overview
• 5.111 Shield Diagnostics Company Overview
• 5.112 Singapore Biomicro Pte Ltd Company Overview
• 5.113 Socrates Health Solutions, Inc. Company Overview
• 5.114 Spire Corp Company Overview
• 5.115 St. Louis Medical Devices Inc (Inactive) Company Overview
• 5.116 Stony Brook University Company Overview
• 5.117 Swansea University Company Overview
• 5.118 TecMed Inc Company Overview
• 5.119 Tenax Therapeutics Inc Company Overview
• 5.120 Terumo Corp Company Overview
• 5.121 Texas A&M University Company Overview
• 5.122 Ultradian Diagnostics LLC Company Overview
• 5.123 University of California Berkeley Company Overview
• 5.124 University of California Irvine Company Overview
• 5.125 University of California San Diego Company Overview
• 5.126 University of Central Florida Company Overview
• 5.127 University of South Carolina Company Overview
• 5.128 University of South Florida Company Overview
• 5.129 University of Technology Sydney Company Overview
• 5.130 University of Texas at Arlington Company Overview
• 5.131 VeriTeQ Corporation Company Overview
• 5.132 Virginia Commonwealth University Company Overview
• 5.133 Vytrace, Inc. Company Overview
• 5.134 WaveForm Technologies Inc Company Overview
• 5.135 Xcellence in Bio Innovations & Technologies Pvt Ltd Company Overview
• 5.136 Zansors LLC Company Overview
• 5.137 Zyvex Corp Company Overview

6 Blood Glucose Meters- Recent Developments

• 6.1 Jun 27, 2019: FDA warns patients and health care providers about potential cybersecurity concerns with certain Medtronic insulin pumps
• 6.2 Jun 26, 2019: Universal Biosensors: Business Update
• 6.3 Jun 25, 2019: ConvaTec Group: Board Change
• 6.4 Jun 19, 2019: DECN narrows choices of likely strategic partners to two, serious talks begin
• 6.5 Jun 18, 2019: Senzime contracts new CFO
• 6.6 Jun 17, 2019: Nemaura provides fiscal 2019 year-end business update
• 6.7 Jun 14, 2019: Announcement of new appointments to Board of Directors at PHC Holdings and PHC
• 6.8 Jun 11, 2019: Abbott's FreeStyle device helps significantly reduce glucose levels
• 6.9 Jun 11, 2019: DarioHealth reports improvement in glycemic outcomes with key diabetes findings at the American Diabetes Association's 79th Scientific Sessions

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

• Table 1: Blood Glucose Meters - Pipeline Products by Stage of Development
• Table 2: Blood Glucose Meters - Pipeline Products by Segment
• Table 3: Blood Glucose Meters - Pipeline Products by Territory
• Table 4: Blood Glucose Meters - Pipeli

List of Figures

• Figure 1: Blood Glucose Meters - Pipeline Products by Stage of Development
• Figure 2: Blood Glucose Meters - Pipeline Products by Segment
• Figure 3: Blood Glucose Meters - Pipeline Products by Territory
• Figure 4: Blood Glucose Meters - P